Senior Scientist / Principal Scientist – Bioinformatics

  • Closing date 15 Jan 2021
  • Type Full-time
  • Duration Permanent

Cerevance is a pharmaceutical company harnessing a novel technology platform to deliver life-changing therapeutics for patients with central nervous system diseases. Cerevance is generating a large and diverse human CNS expression and epigenetics data set from which new targets are being identified for innovative drug discovery programmes. We are seeking to recruit a Bioinformatician to join our bioinformatics group, based in our Cambridge, UK facility.

 

Key responsibilities:

 

Providing support for the CNS expression and epigenetics project, including analysis, data integration and systems approaches. Identification of novel drug targets is a key output. Application of statistically robust methods is essential.

 

Conducting ad-hoc bioinformatics analyses in support of various internal projects, including analysis of internal and public domain expression data, public domain association studies, known variants, and pathway and network analysis.

 

Maintaining a close iterative relationship with the biology teams that generate and consume data. You will provide analysis results in easily accessible formats and guide these teams in their use.

 

Requirements:

 

The ideal candidate will have a relevant MSc with at least 3 years industry experience, or a relevant PhD, experience of working in bioinformatics and a strong record of creativity. You will possess excellent technical informatics and applied statistics skills. Experience with RNA-Seq and R/Bioconductor is essential, experience with epigenetics data, GWAS and other genetic studies and a knowledge of neurobiology would be beneficial.

 

Good interpersonal and communication skills are essential as you will be working closely with our scientists in support of our research projects.

 

Cerevance offers competitive salary and benefits packages. Covering letter and CV should be sent to [email protected] by the closing date of 15th January.

 

Contact us

Thank you for your enquiry!
We'll be in touch soon.

We couldn't send your message.
Please review the fields then try again